КОРТИЗОЛСЕКРЕТИРУЮЩИЕ ОБРАЗОВАНИЯ НАДПОЧЕЧНИКОВ: ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
явилось изучение клинических особенностей кортизолсекретирующих образований надпочечников.
Article Details
Как цитировать:
Библиографические ссылки:
Castinetti F, Morange I, Conte-Devolx B, Brue T. Cushing’s disease. Orphanet J Rare Dis. 2012; 7:41. doi: 10.1186/1750-1172-7-41
Clayton RN, Jones PW, Reulen RC, et al. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol 2016; 4:569-76.
Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2(5):396–405.
Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of adrenal Cushing’s syndrome. J ClinPathol. 2015;68(3):175–186.
Frustaci A, Letizia C, Verardo R, Grande C, Petramala L, Russo MA, Chimenti C. Cushing Syndrome Cardiomyopathy: Clinicopathologic Impact of Cortisol Normalization. CircCardiovasc Imaging. 2016;9(4):e004569.
Graversen D, Vestergaard P, Stochholm K, Gravholt CH, Jorgensen JO. Mortality in Cushing's syndrome: a systematic review and meta-analysis. Eur J Intern Med. 2012;23(3):278–82.
Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015;386(9996):913-27.
Loriaux DL. Diagnosis and differential diagnosis of Cushing’s syndrome. N Engl J Med. 2017;376(15):1451–1459.
Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, Berland LL, Pandharipande PV. Management of incidental adrenal masses: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2017;14(8):1038–1044.
Morelli V, Eller-Vainicher C, Palmieri S, Cairoli E, Salcuni AS, Scillitani A, Carnevale V, Corbetta S, Arosio M, Della Casa S, Muscogiuri G, Spada A, Chiodini I. Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas. J Clin Endocrinol Metab. 2016;101(7):2768–2775.
Nieman LK. Cushing’s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol 2015; 173:M33–M38
Santos A, Resmini E, Gómez-Ansón B, Crespo I, Granell E, Valassi E, et al. Cardiovascular risk and white matter lesions after endocrine control of Cushing’s syndrome. Eur J Endocrinol. 2015 173:765–75. doi: 10.1530/EJE-15-0600
Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol 2015; 7:281–293
Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, Waguespack SG, Elsayes KM. Cushing Syndrome: Diagnostic Workup and Imaging Features, With Clinical and Pathologic Correlation. AJR Am J Roentgenol 2017;209:19-32. 10.2214/AJR.16.17290
Yorke E, Atiase Y, Akpalu J, Sarfo-Kantanka O. Screening for Cushing syndrome at the primary care level: what every general practitioner must know. Int J Endocrinol. 2017;2017:1547358.